APA (7th ed.) Citation

S, S., BA, D., AD, C., DT, V., S, R., A, R., . . . N, B. (2026). Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: Insights from a multicenter case series. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01473-3

Chicago Style (17th ed.) Citation

S, Susanibar-Adaniya, et al. "Immune Effector Cell-associated Enterocolitis Post-BCMA Directed CAR T-cell Therapy: Insights from a Multicenter Case Series." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01473-3.

MLA (9th ed.) Citation

S, Susanibar-Adaniya, et al. "Immune Effector Cell-associated Enterocolitis Post-BCMA Directed CAR T-cell Therapy: Insights from a Multicenter Case Series." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01473-3.